Southern California TMS Center

Southern California TMS Center in West Los Angeles, California provides Spravato (esketamine) for treatment-resistant depression, a self-administered FDA-approved nasal spray delivered under medical supervision in a comfortable clinical setting. SoCal TMS has led Southern California in interventional depression care since 2009 and added esketamine in 2019, offering it alongside TMS therapy for patients whose major depression hasn't responded to medication.

The practice is led by board-certified psychiatrists with experienced technicians and case managers who prioritize patient needs. Spravato is covered by most insurance plans. The clinic serves West Los Angeles and the surrounding Los Angeles County communities.